,Set,NGenes,Direction,PValue,FDR
1,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Down,2.07684899221553e-07,0.000171340041857781
2,WP_OXIDATIVE_PHOSPHORYLATION,50,Down,7.42222884880128e-07,0.000306166940013053
3,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Down,4.37522464753188e-06,0.00120318677807127
4,WP_COMPLEMENT_ACTIVATION,11,Down,4.96130567014508e-05,0.0102326929446742
5,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Up,0.000324907005394885,0.053609655890156
6,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Down,0.000904310265655951,0.124342661527693
7,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,128,Down,0.00129789438571266,0.150458673341048
8,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Down,0.00162540351484876,0.150458673341048
9,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,5,Down,0.0016413673455387,0.150458673341048
10,WP_OXIDATIVE_STRESS_RESPONSE,21,Down,0.00206855635101329,0.170655898958597
11,WP_SELENIUM_MICRONUTRIENT_NETWORK,50,Down,0.0031736459118239,0.238023443386792
12,WP_OXIDATIVE_DAMAGE_RESPONSE,33,Down,0.00490095738228444,0.308149063656444
13,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,11,Up,0.0054349208261644,0.308149063656444
14,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Up,0.00552311092696772,0.308149063656444
15,WP_FERROPTOSIS,48,Down,0.00583476567228656,0.308149063656444
16,WP_COMPLEMENT_SYSTEM,53,Down,0.00597622426485225,0.308149063656444
17,WP_LIVER_X_RECEPTOR_PATHWAY,5,Down,0.00769779170831369,0.341991409413235
18,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Down,0.00822691248752273,0.341991409413235
19,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,10,Down,0.00946062577169694,0.341991409413235
20,WP_G1_TO_S_CELL_CYCLE_CONTROL,49,Down,0.00953395413944686,0.341991409413235
21,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,8,Up,0.0096261264410253,0.341991409413235
22,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Down,0.00963970870846988,0.341991409413235
23,WP_TP53_NETWORK,14,Down,0.00989297292499821,0.341991409413235
24,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,5,Up,0.0099488410011123,0.341991409413235
25,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,63,Down,0.0103875696979093,0.342789800031008
26,WP_ATR_SIGNALING,10,Down,0.0134988324483428,0.428328337303186
27,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,55,Down,0.0157968819144719,0.482682502942198
28,WP_DNA_MISMATCH_REPAIR,21,Down,0.0167690790097679,0.494088935109232
29,WP_SMALL_LIGAND_GPCRS,7,Up,0.017573291846729,0.499929854260394
30,WP_ALLOGRAFT_REJECTION,50,Down,0.018602406188799,0.511566170191971
31,WP_FATTY_ACID_TRANSPORTERS,10,Down,0.0223993380240503,0.565945146717945
32,WP_BIOGENIC_AMINE_SYNTHESIS,1,Down,0.0231506031555611,0.565945146717945
33,WP_NEUROTRANSMITTER_DISORDERS,1,Down,0.0231506031555611,0.565945146717945
34,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,27,Up,0.0238794717245639,0.565945146717945
35,WP_DOPAMINE_METABOLISM,7,Down,0.0241731559736104,0.565945146717945
36,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,8,Down,0.0246957882204194,0.565945146717945
37,WP_RETT_SYNDROME,30,Up,0.0258714915269827,0.576864338101641
38,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Down,0.0270675461784859,0.581018046407372
39,WP_ESTROGEN_METABOLISM_WP5276,9,Down,0.0298132962176712,0.581018046407372
40,WP_ID_SIGNALING,11,Down,0.0300947065320202,0.581018046407372
41,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Up,0.031118345295222,0.581018046407372
42,WP_FOXA2_PATHWAY,9,Down,0.0312375659039194,0.581018046407372
43,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,47,Up,0.0317469915114017,0.581018046407372
44,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Up,0.0333072096722543,0.581018046407372
45,WP_DNA_DAMAGE_RESPONSE,57,Down,0.0334231937409771,0.581018046407372
46,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,26,Up,0.0334903116185148,0.581018046407372
47,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.0339065042573192,0.581018046407372
48,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,16,Up,0.0342194411850842,0.581018046407372
49,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,43,Up,0.0345089506351045,0.581018046407372
50,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,33,Up,0.0367798738667427,0.606867918801255
51,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,58,Down,0.0433089809037901,0.700586455796604
52,WP_NUCLEAR_RECEPTORS_METAPATHWAY,176,Down,0.0447160971089772,0.709438079132812
53,WP_ESTROGEN_METABOLISM_WP697,6,Down,0.0469849060158936,0.709533197549542
54,WP_ETHER_LIPID_BIOSYNTHESIS,15,Up,0.0469927791962451,0.709533197549542
55,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Down,0.0474588448698494,0.709533197549542
56,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Down,0.0483972083018747,0.709533197549542
57,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Up,0.0507941267733539,0.709533197549542
58,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,3,Up,0.0513368713538915,0.709533197549542
59,WP_INFLAMMATORY_RESPONSE_PATHWAY,13,Down,0.0517837778176131,0.709533197549542
60,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Down,0.0519270779227842,0.709533197549542
61,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,20,Down,0.053149510787777,0.709533197549542
62,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,26,Up,0.0533224948461474,0.709533197549542
63,WP_FLUOROPYRIMIDINE_ACTIVITY,25,Up,0.0579489985620048,0.745273256161772
64,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,48,Down,0.0603303939847559,0.745273256161772
65,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Up,0.0604035348676169,0.745273256161772
66,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Down,0.061350766055983,0.745273256161772
67,WP_COMPLEMENT_AND_COAGULATION_CASCADES,25,Down,0.0614285835381824,0.745273256161772
68,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,25,Down,0.0614285835381824,0.745273256161772
69,WP_GASTRIC_CANCER_NETWORK_1,16,Up,0.0627819467486618,0.748570320750123
70,WP_PPARALPHA_PATHWAY,16,Down,0.0642073108796743,0.748570320750123
71,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.0649906858742182,0.748570320750123
72,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Up,0.0655955715301806,0.748570320750123
73,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Down,0.066237131411829,0.748570320750123
74,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Up,0.0680423433421923,0.75858017915282
75,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,11,Down,0.0713524776197831,0.774741355732705
76,WP_SPINA_BIFIDA,10,Up,0.071370112770528,0.774741355732705
77,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,28,Down,0.0730354333080822,0.776059743875896
78,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Down,0.0733729212391756,0.776059743875896
79,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,37,Down,0.0752802555784211,0.784343676352868
80,WP_ESTROGEN_RECEPTOR_PATHWAY,9,Down,0.0762731296636179,0.784343676352868
81,WP_SILDENAFIL_TREATMENT,11,Down,0.0775261273083928,0.784343676352868
82,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,34,Down,0.0784007126564712,0.784343676352868
83,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Down,0.0812741562040697,0.784343676352868
84,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,51,Up,0.0815129180128797,0.784343676352868
85,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Up,0.0816997078712305,0.784343676352868
86,WP_MEVALONATE_PATHWAY,7,Up,0.0817618862622383,0.784343676352868
87,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,17,Down,0.082921924247458,0.786328592001757
88,WP_FATTY_ACID_BETAOXIDATION,28,Down,0.0842552501279615,0.789892969949639
89,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,8,Up,0.085723427645516,0.794627278736525
90,WP_ANGIOGENESIS,14,Down,0.0873131257808946,0.795536548338532
91,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Up,0.0882964435917661,0.795536548338532
92,WP_PPAR_SIGNALING,37,Down,0.0894426396371861,0.795536548338532
93,WP_DNA_REPLICATION,34,Down,0.0908031985824083,0.795536548338532
94,WP_CELL_CYCLE,88,Down,0.0914503756821226,0.795536548338532
95,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Up,0.0924452865879852,0.795536548338532
96,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,19,Down,0.0938305564282544,0.795536548338532
97,WP_PANCREATIC_CANCER_SUBTYPES,5,Down,0.0944792511847552,0.795536548338532
98,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,14,Up,0.0954520702107492,0.795536548338532
99,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,2,Down,0.0954643858006238,0.795536548338532
100,WP_FATTY_ACID_BIOSYNTHESIS,21,Down,0.099064872289221,0.817285196386073
101,WP_SERINE_METABOLISM,7,Up,0.100194172472598,0.818417745444491
102,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,62,Up,0.101266657565621,0.819068553839578
103,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,12,Up,0.102502024250972,0.821011359291763
104,WP_PRION_DISEASE_PATHWAY,29,Up,0.107065901709148,0.841825410023464
105,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Down,0.108160048112466,0.841825410023464
106,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Up,0.10816181025756,0.841825410023464
107,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Up,0.109422395588219,0.843677349161501
108,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,70,Down,0.110637363392356,0.84514652591383
109,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Down,0.114789650550657,0.868820749580657
110,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.11677705006,0.875827875449999
111,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Down,0.118009559500186,0.877098077366246
112,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Up,0.119386176207053,0.879407101525164
113,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,44,Down,0.121730847627515,0.886276184084165
114,WP_ATM_SIGNALING,33,Down,0.123489856342536,0.886276184084165
115,WP_16P112_DISTAL_DELETION_SYNDROME,21,Down,0.123726036934854,0.886276184084165
116,WP_SULINDAC_METABOLIC_PATHWAY,3,Down,0.127891563220601,0.886276184084165
117,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Down,0.127895105361743,0.886276184084165
118,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,24,Down,0.128304342957778,0.886276184084165
119,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Down,0.129114888801699,0.886276184084165
120,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Up,0.129509149178039,0.886276184084165
121,WP_PURINE_METABOLISM,10,Down,0.132187596131545,0.886276184084165
122,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,12,Down,0.135788307178587,0.886276184084165
123,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,62,Down,0.137358542106778,0.886276184084165
124,WP_BENZOAPYRENE_METABOLISM,4,Down,0.13773657561879,0.886276184084165
125,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Down,0.138247239491344,0.886276184084165
126,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Up,0.138755928276823,0.886276184084165
127,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Up,0.139695714856137,0.886276184084165
128,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Up,0.139800081070277,0.886276184084165
129,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,8,Up,0.141323170546678,0.886276184084165
130,WP_CELL_DIFFERENTIATION_INDEX,7,Up,0.142153962413735,0.886276184084165
131,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Down,0.142485746329748,0.886276184084165
132,WP_IRON_METABOLISM_IN_PLACENTA,9,Down,0.142991128225182,0.886276184084165
133,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,20,Down,0.144700153939027,0.886276184084165
134,WP_SLEEP_REGULATION,10,Down,0.145668819134722,0.886276184084165
135,WP_ONCOSTATIN_M_SIGNALING,56,Down,0.146136513666363,0.886276184084165
136,WP_LEPTIN_AND_ADIPONECTIN,8,Down,0.148114105214755,0.886276184084165
137,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,47,Down,0.148829396707694,0.886276184084165
138,WP_MONOAMINE_GPCRS,3,Up,0.150821053379097,0.886276184084165
139,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Up,0.150985614300229,0.886276184084165
140,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Down,0.153131228407927,0.886276184084165
141,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,9,Down,0.154155363157391,0.886276184084165
142,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Up,0.155444485242117,0.886276184084165
143,WP_LUNG_FIBROSIS,35,Up,0.157303526266805,0.886276184084165
144,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,11,Up,0.15830035674604,0.886276184084165
145,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,12,Up,0.159652142282192,0.886276184084165
146,WP_ALSTROM_SYNDROME,27,Down,0.160636760886191,0.886276184084165
147,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,29,Down,0.160687303962482,0.886276184084165
148,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Up,0.161468528942734,0.886276184084165
149,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Up,0.161498517173088,0.886276184084165
150,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,43,Up,0.163744136531245,0.886276184084165
151,WP_GLYCOSPHINGOLIPID_METABOLISM,12,Down,0.16644353762162,0.886276184084165
152,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,6,Up,0.166578951780206,0.886276184084165
153,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Up,0.172574825891196,0.886276184084165
154,WP_GALANIN_RECEPTOR_PATHWAY,11,Down,0.174249580580234,0.886276184084165
155,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Down,0.17439548888058,0.886276184084165
156,WP_PHOSPHOINOSITIDES_METABOLISM,37,Up,0.174701256175057,0.886276184084165
157,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,164,Down,0.175351080389447,0.886276184084165
158,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,47,Down,0.175537166304334,0.886276184084165
159,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Up,0.177379248211388,0.886276184084165
160,WP_TRANSSULFURATION_PATHWAY,8,Up,0.178481931427888,0.886276184084165
161,WP_VITAMIN_D_RECEPTOR_PATHWAY,84,Down,0.178705208952765,0.886276184084165
162,WP_AGERAGE_PATHWAY,55,Down,0.179111793088795,0.886276184084165
163,WP_IRON_METABOLISM_DISORDERS,12,Down,0.180168513644209,0.886276184084165
164,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,2,Up,0.181322314910113,0.886276184084165
165,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Up,0.18142203264418,0.886276184084165
166,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,24,Down,0.18360897097177,0.886276184084165
167,WP_FATTY_ACID_OMEGAOXIDATION,2,Down,0.186764772428838,0.886276184084165
168,WP_SPINAL_CORD_INJURY,65,Down,0.188029300105979,0.886276184084165
169,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,23,Up,0.188036613983284,0.886276184084165
170,WP_NRF2ARE_REGULATION,21,Down,0.188465256237626,0.886276184084165
171,WP_UROTENSINIIMEDIATED_SIGNALING,49,Down,0.188834069075463,0.886276184084165
172,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Down,0.188866606232613,0.886276184084165
173,WP_PROXIMAL_TUBULE_TRANSPORT,25,Down,0.189858825668822,0.886276184084165
174,WP_TAMOXIFEN_METABOLISM,3,Down,0.190353454470575,0.886276184084165
175,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,76,Down,0.190443194352563,0.886276184084165
176,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Down,0.190512255264832,0.886276184084165
177,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,7,Up,0.192709137770424,0.886276184084165
178,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,8,Down,0.193101928979323,0.886276184084165
179,WP_PROTEASOME_DEGRADATION,57,Down,0.193351428095653,0.886276184084165
180,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,42,Down,0.194072574347267,0.886276184084165
181,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,17,Down,0.194443623417253,0.886276184084165
182,WP_PURINERGIC_SIGNALING,16,Up,0.195965143778478,0.888303536358487
183,WP_AUTOPHAGY,27,Down,0.199567750050823,0.890051572865326
184,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,16,Down,0.199626107731856,0.890051572865326
185,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Down,0.200449033288776,0.890051572865326
186,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Up,0.207544707193576,0.890051572865326
187,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,9,Down,0.208194859137801,0.890051572865326
188,WP_CELLULAR_PROTEOSTASIS,6,Down,0.211040647614823,0.890051572865326
189,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,15,Down,0.21138197692529,0.890051572865326
190,WP_PRIMARY_OVARIAN_INSUFFICIENCY,87,Down,0.211475540616702,0.890051572865326
191,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,23,Up,0.213964169962255,0.890051572865326
192,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,37,Down,0.215498652549935,0.890051572865326
193,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Up,0.215940460485608,0.890051572865326
194,WP_CANONICAL_NFKB_PATHWAY,8,Down,0.216116263395131,0.890051572865326
195,WP_NRF2_PATHWAY,69,Down,0.218380392134331,0.890051572865326
196,WP_PTF1A_RELATED_REGULATORY_PATHWAY,5,Up,0.219256089814997,0.890051572865326
197,WP_ENERGY_METABOLISM,41,Up,0.219442603305849,0.890051572865326
198,WP_RETINOBLASTOMA_GENE_IN_CANCER,66,Down,0.220204448629255,0.890051572865326
199,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,16,Down,0.221602022280171,0.890051572865326
200,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,34,Up,0.222062921031123,0.890051572865326
201,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Up,0.222104741536125,0.890051572865326
202,WP_KREBS_CYCLE_DISORDERS,11,Up,0.222767348472137,0.890051572865326
203,WP_BLADDER_CANCER,30,Down,0.223742099363596,0.890051572865326
204,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,16,Up,0.224091756815296,0.890051572865326
205,WP_JOUBERT_SYNDROME,66,Up,0.224953192994991,0.890051572865326
206,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,14,Down,0.22535016128133,0.890051572865326
207,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,14,Up,0.226568369518829,0.890051572865326
208,WP_NAD_METABOLISM,11,Down,0.227538751752909,0.890051572865326
209,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,18,Up,0.230659468131765,0.890051572865326
210,WP_INTEGRATED_CANCER_PATHWAY,38,Down,0.230776483577152,0.890051572865326
211,WP_P38_MAPK_SIGNALING,31,Down,0.23269735776281,0.890051572865326
212,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,15,Up,0.238985300732375,0.890051572865326
213,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,62,Up,0.239892138724282,0.890051572865326
214,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Down,0.240584614862006,0.890051572865326
215,WP_TRIACYLGLYCERIDE_SYNTHESIS,17,Down,0.241206082380245,0.890051572865326
216,WP_NAD_BIOSYNTHETIC_PATHWAYS,18,Down,0.242370022031009,0.890051572865326
217,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,33,Up,0.244457446958296,0.890051572865326
218,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Up,0.24554860830763,0.890051572865326
219,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,26,Down,0.245776108669023,0.890051572865326
220,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Down,0.245982499850093,0.890051572865326
221,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,82,Down,0.246396481366933,0.890051572865326
222,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Down,0.246950236365709,0.890051572865326
223,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Down,0.247242981932124,0.890051572865326
224,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Up,0.247580019961888,0.890051572865326
225,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,11,Up,0.24971092840503,0.890051572865326
226,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,7,Down,0.250955787112086,0.890051572865326
227,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Up,0.253082282326654,0.890051572865326
228,WP_OSTEOCLAST_SIGNALING,9,Down,0.253504883961923,0.890051572865326
229,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,9,Down,0.253774763424442,0.890051572865326
230,WP_ENDOTHELIN_PATHWAYS,12,Up,0.254113576052919,0.890051572865326
231,WP_NEPHROGENESIS,3,Down,0.254764573776819,0.890051572865326
232,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,11,Down,0.258187078740674,0.890051572865326
233,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,46,Up,0.258234869003212,0.890051572865326
234,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,5,Up,0.258726372710448,0.890051572865326
235,WP_NEURAL_CREST_DIFFERENTIATION,35,Up,0.25912325239013,0.890051572865326
236,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Up,0.262798974581549,0.890051572865326
237,WP_LEPTININSULIN_SIGNALING_OVERLAP,12,Down,0.263093036054335,0.890051572865326
238,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Up,0.264617917411606,0.890051572865326
239,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Up,0.265122164921206,0.890051572865326
240,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,7,Up,0.265175738610474,0.890051572865326
241,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Down,0.271401614647071,0.890051572865326
242,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Up,0.272193255818981,0.890051572865326
243,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Down,0.274104607908199,0.890051572865326
244,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Down,0.274365535504303,0.890051572865326
245,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,16,Up,0.274786752429466,0.890051572865326
246,WP_HEDGEHOG_SIGNALING_WP47,6,Down,0.275472534834652,0.890051572865326
247,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,10,Down,0.278680468802908,0.890051572865326
248,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Up,0.279146906244313,0.890051572865326
249,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Down,0.279168040942093,0.890051572865326
250,WP_5Q35_COPY_NUMBER_VARIATION,75,Down,0.279233309119427,0.890051572865326
251,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Up,0.280281731935714,0.890051572865326
252,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,75,Up,0.280764157884452,0.890051572865326
253,WP_HIPPO_SIGNALING_REGULATION,41,Up,0.280802644372419,0.890051572865326
254,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,28,Down,0.280908659647894,0.890051572865326
255,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Down,0.281281676829921,0.890051572865326
256,WP_LEUKOTRIENE_METABOLIC_PATHWAY,9,Down,0.281624395222712,0.890051572865326
257,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,39,Down,0.283306692847367,0.890051572865326
258,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,2,Down,0.284440516443825,0.890051572865326
259,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,27,Down,0.285077673201801,0.890051572865326
260,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Down,0.285689912735296,0.890051572865326
261,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Down,0.285810845996293,0.890051572865326
262,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Up,0.286060927213357,0.890051572865326
263,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,20,Up,0.286139666210546,0.890051572865326
264,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Down,0.287954750574162,0.890051572865326
265,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,47,Up,0.287973460551683,0.890051572865326
266,WP_IL19_SIGNALING,20,Down,0.288686622173812,0.890051572865326
267,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,8,Up,0.290257725662752,0.890051572865326
268,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Up,0.291556774268443,0.890051572865326
269,WP_APOPTOSIS,69,Down,0.294052816637806,0.890051572865326
270,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Down,0.29409111820035,0.890051572865326
271,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Up,0.29451043383276,0.890051572865326
272,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Up,0.294992954077769,0.890051572865326
273,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.295942670884599,0.890051572865326
274,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Down,0.296804310074561,0.890051572865326
275,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Down,0.297546772284495,0.890051572865326
276,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,58,Down,0.297762708013127,0.890051572865326
277,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,39,Down,0.300480713031029,0.893389790996023
278,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Down,0.301933711785097,0.893389790996023
279,WP_PDGF_PATHWAY,36,Down,0.302617342424771,0.893389790996023
280,WP_ESTROGEN_SIGNALING,21,Down,0.305622357473812,0.893389790996023
281,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,8,Up,0.307631902230324,0.893389790996023
282,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Up,0.308025986408901,0.893389790996023
283,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,14,Up,0.308590740728701,0.893389790996023
284,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,11,Up,0.309440171751545,0.893389790996023
285,WP_AXON_GUIDANCE,33,Down,0.309708847625242,0.893389790996023
286,WP_MEASLES_VIRUS_INFECTION,99,Up,0.311552289068393,0.893389790996023
287,WP_NUCLEOTIDE_GPCRS,7,Up,0.311906268493976,0.893389790996023
288,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,29,Up,0.313070560492111,0.893389790996023
289,WP_KETOGENESIS_AND_KETOLYSIS,5,Down,0.314052248971906,0.893389790996023
290,WP_IL6_SIGNALING,39,Down,0.314864518434899,0.893389790996023
291,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,12,Down,0.315122944460415,0.893389790996023
292,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,15,Down,0.317912392512368,0.8941956616531
293,WP_ANDROGEN_RECEPTOR_SIGNALING,78,Up,0.31955747210564,0.8941956616531
294,WP_DISORDERS_IN_KETOLYSIS,3,Up,0.320775728521424,0.8941956616531
295,WP_FOLATE_METABOLISM,36,Down,0.321415333352925,0.8941956616531
296,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Down,0.321836759103313,0.8941956616531
297,WP_GLIAL_CELL_DIFFERENTIATION,4,Up,0.324369210784528,0.8941956616531
298,WP_MESODERMAL_COMMITMENT_PATHWAY,74,Up,0.325406391676347,0.8941956616531
299,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,1,Up,0.327575160757063,0.8941956616531
300,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,47,Up,0.328882869493421,0.8941956616531
301,WP_GLYOXYLATE_METABOLISM,5,Down,0.329581887936951,0.8941956616531
302,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,64,Down,0.330335149282224,0.8941956616531
303,WP_IL5_SIGNALING,37,Up,0.330781856019854,0.8941956616531
304,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,19,Down,0.33095233657956,0.8941956616531
305,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,51,Up,0.332456735701465,0.8941956616531
306,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,65,Down,0.332946386269984,0.8941956616531
307,WP_7OXOC_AND_7BETAHC_PATHWAYS,16,Down,0.334041187640137,0.8941956616531
308,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Down,0.3363643292136,0.8941956616531
309,WP_HEME_BIOSYNTHESIS,8,Down,0.3363643292136,0.8941956616531
310,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,32,Up,0.336996173509615,0.8941956616531
311,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,56,Down,0.337420353674673,0.8941956616531
312,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,53,Up,0.338622772678481,0.8941956616531
313,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,18,Down,0.339381790659629,0.8941956616531
314,WP_IL7_SIGNALING,24,Down,0.342661098129447,0.8941956616531
315,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,45,Up,0.3438214478303,0.8941956616531
316,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,9,Down,0.343959625070341,0.8941956616531
317,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Down,0.34557748533211,0.8941956616531
318,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Up,0.346002398398774,0.8941956616531
319,WP_ASPIRIN_AND_MIRNAS,8,Down,0.348604791158669,0.8941956616531
320,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,112,Down,0.348817640604727,0.8941956616531
321,WP_THIAMINE_METABOLIC_PATHWAYS,9,Down,0.34909336114593,0.8941956616531
322,WP_FOCAL_ADHESION,117,Up,0.350565956563533,0.8941956616531
323,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,3,Down,0.350695817015909,0.8941956616531
324,WP_KLEEFSTRA_SYNDROME,25,Up,0.351605952649133,0.8941956616531
325,WP_RAC1PAK1P38MMP2_PATHWAY,52,Down,0.352258897014858,0.8941956616531
326,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,12,Up,0.355098300288818,0.898638336620474
327,WP_INSULIN_SIGNALING,127,Down,0.357303911980319,0.898810346000923
328,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Up,0.357345204228246,0.898810346000923
329,WP_ERBB_SIGNALING,68,Down,0.358651837956519,0.899354912808899
330,WP_ADIPOGENESIS,80,Down,0.360832794109462,0.900391556973344
331,WP_4P163_COPY_NUMBER_VARIATION,21,Up,0.362185694774275,0.900391556973344
332,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,77,Down,0.362339390200182,0.900391556973344
333,WP_ONECARBON_METABOLISM,22,Up,0.364653409144423,0.902754711730987
334,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Up,0.365478877234121,0.902754711730987
335,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,50,Up,0.367329004603387,0.904616205366551
336,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Up,0.370115989600176,0.904864826034061
337,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,16,Up,0.370929561472758,0.904864826034061
338,WP_CIRCADIAN_RHYTHM_GENES,113,Down,0.371157564188074,0.904864826034061
339,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,11,Down,0.374915315857924,0.904864826034061
340,WP_OXIDATION_BY_CYTOCHROME_P450,16,Down,0.375643780417985,0.904864826034061
341,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,41,Up,0.377048527150424,0.904864826034061
342,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.377327839831309,0.904864826034061
343,WP_TYPE_II_DIABETES_MELLITUS,12,Down,0.379731040323138,0.904864826034061
344,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,86,Down,0.382056840561996,0.904864826034061
345,WP_REGULATION_OF_ACTIN_CYTOSKELETON,88,Up,0.383930754699048,0.904864826034061
346,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Up,0.384648176056075,0.904864826034061
347,WP_BLOOD_CLOTTING_CASCADE,6,Up,0.385209831376565,0.904864826034061
348,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,10,Up,0.386477817473793,0.904864826034061
349,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,12,Up,0.386998665549301,0.904864826034061
350,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Down,0.388334499713178,0.904864826034061
351,WP_GLUTATHIONE_METABOLISM,10,Down,0.388572569915985,0.904864826034061
352,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,4,Down,0.38917431785082,0.904864826034061
353,WP_ECTODERM_DIFFERENTIATION,72,Up,0.390344892357932,0.904864826034061
354,WP_TYPE_II_INTERFERON_SIGNALING,31,Up,0.391063298218047,0.904864826034061
355,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Down,0.394304957305618,0.904864826034061
356,WP_POSTCOVID_NEUROINFLAMMATION,13,Up,0.39535414943167,0.904864826034061
357,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,19,Down,0.397201000849205,0.904864826034061
358,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,30,Up,0.39802522383602,0.904864826034061
359,WP_TNFALPHA_SIGNALING,81,Down,0.398188058804774,0.904864826034061
360,WP_GABA_METABOLISM_AKA_GHB,4,Down,0.398703128569744,0.904864826034061
361,WP_NOTCH_SIGNALING_WP61,49,Up,0.400008807449838,0.904864826034061
362,WP_10Q22Q23_COPY_NUMBER_VARIATION,25,Up,0.400710953565577,0.904864826034061
363,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Down,0.401395008936082,0.904864826034061
364,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Up,0.403094574508175,0.904864826034061
365,WP_SYNAPTIC_VESICLE_PATHWAY,20,Up,0.403795811061239,0.904864826034061
366,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Down,0.403810900488448,0.904864826034061
367,WP_15Q25_COPY_NUMBER_VARIATION,27,Down,0.404339637140759,0.904864826034061
368,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,19,Down,0.405158577516034,0.904864826034061
369,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Down,0.407852060638347,0.904864826034061
370,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Down,0.407852060638347,0.904864826034061
371,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,36,Up,0.409253194573604,0.904864826034061
372,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,60,Up,0.409702741501471,0.904864826034061
373,WP_IL4_SIGNALING,50,Down,0.412244126016754,0.904864826034061
374,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,38,Up,0.41262737013322,0.904864826034061
375,WP_ULCERATIVE_COLITIS_SIGNALING,13,Down,0.412836330717254,0.904864826034061
376,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,8,Up,0.413768088345981,0.904864826034061
377,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,18,Up,0.414597073197375,0.904864826034061
378,WP_PAFAH1B1_COPY_NUMBER_VARIATION,8,Up,0.416860393764749,0.904864826034061
379,WP_IL26_SIGNALING,33,Down,0.417910539834307,0.904864826034061
380,WP_IDO_METABOLIC_PATHWAY,6,Up,0.419071887194919,0.904864826034061
381,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,77,Down,0.421308758623386,0.904864826034061
382,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Down,0.421637527346739,0.904864826034061
383,WP_ARYLAMINE_METABOLISM,1,Down,0.423072025355126,0.904864826034061
384,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Up,0.423234605989635,0.904864826034061
385,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Down,0.425973393578049,0.904864826034061
386,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Down,0.427907319127238,0.904864826034061
387,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Up,0.428549224331341,0.904864826034061
388,WP_NGLYCAN_BIOSYNTHESIS,52,Up,0.429249160180785,0.904864826034061
389,WP_CHEMOKINE_SIGNALING,115,Up,0.430716248929618,0.904864826034061
390,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,24,Down,0.431853567651426,0.904864826034061
391,WP_ENDODERM_DIFFERENTIATION,82,Up,0.432164595889001,0.904864826034061
392,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,30,Up,0.432860466425325,0.904864826034061
393,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,38,Down,0.433102748619811,0.904864826034061
394,WP_CILIARY_LANDSCAPE,182,Down,0.433659542992638,0.904864826034061
395,WP_NONHOMOLOGOUS_END_JOINING,10,Down,0.433898767885169,0.904864826034061
396,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,2,Down,0.434335116496349,0.904864826034061
397,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,50,Down,0.435466897481676,0.904937507361165
398,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Down,0.437582922107331,0.905371930988773
399,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Up,0.437870788441843,0.905371930988773
400,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,13,Up,0.439954598492205,0.907406359390174
401,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,80,Up,0.444434373440676,0.912996549267999
402,WP_PYRIMIDINE_METABOLISM,70,Down,0.445084691188819,0.912996549267999
403,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,7,Down,0.445984981036368,0.912996549267999
404,WP_TGFB_SMAD_SIGNALING,6,Up,0.447193771982029,0.913182738923251
405,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,13,Down,0.448364488216535,0.913182738923251
406,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,10,Up,0.450574299064385,0.913182738923251
407,WP_16P112_PROXIMAL_DELETION_SYNDROME,61,Up,0.454567793070037,0.913182738923251
408,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Up,0.456027605115423,0.913182738923251
409,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,17,Up,0.457344568952875,0.913182738923251
410,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Down,0.45831358627008,0.913182738923251
411,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,13,Down,0.459462251646811,0.913182738923251
412,WP_SMALL_CELL_LUNG_CANCER,64,Down,0.45993254319584,0.913182738923251
413,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,20,Up,0.460259666189131,0.913182738923251
414,WP_UNFOLDED_PROTEIN_RESPONSE,24,Up,0.460777936188243,0.913182738923251
415,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,270,Down,0.462206776239612,0.913182738923251
416,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,27,Up,0.464242698024962,0.913182738923251
417,WP_GLIOBLASTOMA_SIGNALING,65,Down,0.464922960267993,0.913182738923251
418,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,17,Up,0.467284379500535,0.913182738923251
419,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Down,0.47307885881113,0.913182738923251
420,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Down,0.474193317582565,0.913182738923251
421,WP_KALLMANN_SYNDROME,11,Down,0.476115037174233,0.913182738923251
422,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,20,Down,0.476269905180247,0.913182738923251
423,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,7,Up,0.476803912047382,0.913182738923251
424,WP_THERMOGENESIS,74,Up,0.477708318674136,0.913182738923251
425,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,33,Down,0.478440021773607,0.913182738923251
426,WP_NOTCH_SIGNALING_WP268,34,Up,0.480239390168359,0.913182738923251
427,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Down,0.481088781257498,0.913182738923251
428,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,29,Up,0.481780851712749,0.913182738923251
429,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.482360446610656,0.913182738923251
430,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,20,Down,0.48299529322381,0.913182738923251
431,WP_AFLATOXIN_B1_METABOLISM,2,Down,0.483358498277763,0.913182738923251
432,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Down,0.484009781215894,0.913182738923251
433,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Down,0.487463743117748,0.913182738923251
434,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,8,Down,0.489043942643785,0.913182738923251
435,WP_PARKINSONS_DISEASE_PATHWAY,25,Down,0.489606202465919,0.913182738923251
436,WP_ACE_INHIBITOR_PATHWAY,4,Down,0.491286254853998,0.913182738923251
437,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Down,0.492198887674318,0.913182738923251
438,WP_LUNG_PATHOLOGY_OF_COVID19,16,Down,0.492470471885596,0.913182738923251
439,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Down,0.495588576369776,0.913182738923251
440,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,101,Down,0.496641355937951,0.913182738923251
441,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Up,0.497717918180077,0.913182738923251
442,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Down,0.498406226267245,0.913182738923251
443,WP_GLUCURONIDATION,7,Down,0.4984643936939,0.913182738923251
444,WP_NEUROINFLAMMATION,10,Down,0.49917189901301,0.913182738923251
445,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,11,Up,0.500069794453786,0.913182738923251
446,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,27,Up,0.500747728116302,0.913182738923251
447,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,5,Down,0.504263071208498,0.913182738923251
448,WP_MITOCHONDRIAL_BETAOXIDATION,8,Down,0.505387020703583,0.913182738923251
449,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,36,Down,0.509170665288718,0.913182738923251
450,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Down,0.50963151405934,0.913182738923251
451,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Down,0.510363474141092,0.913182738923251
452,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,17,Up,0.51051779584091,0.913182738923251
453,WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE,1,Up,0.512661160370385,0.913182738923251
454,WP_COVID19_THROMBOSIS_AND_ANTICOAGULATION,1,Up,0.51380319902722,0.913182738923251
455,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,40,Down,0.515350203538404,0.913182738923251
456,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Down,0.517118478158833,0.913182738923251
457,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,18,Down,0.517924115807384,0.913182738923251
458,WP_CANNABINOID_RECEPTOR_SIGNALING,17,Down,0.51827327759459,0.913182738923251
459,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.518552286776299,0.913182738923251
460,WP_PEPTIDE_GPCRS,14,Up,0.520119830094936,0.913182738923251
461,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Up,0.520705912489735,0.913182738923251
462,WP_ACUTE_MYELOID_LEUKEMIA,56,Up,0.523318240148751,0.913182738923251
463,WP_SULFATASE_AND_AROMATASE_PATHWAY,3,Down,0.524963562899414,0.913182738923251
464,WP_CREATINE_PATHWAY,2,Up,0.52743605244391,0.913182738923251
465,WP_TCELL_RECEPTOR_SIGNALING,73,Up,0.527445633115315,0.913182738923251
466,WP_G13_SIGNALING,30,Up,0.527847173587317,0.913182738923251
467,WP_NEPHROTIC_SYNDROME,26,Up,0.529142716852588,0.913182738923251
468,WP_INCLUSION_BODY_MYOSITIS,9,Down,0.529225241702188,0.913182738923251
469,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Up,0.529267231321381,0.913182738923251
470,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,18,Down,0.529938440256209,0.913182738923251
471,WP_PREIMPLANTATION_EMBRYO,20,Up,0.532204365663832,0.913182738923251
472,WP_CAMKK2_PATHWAY,29,Up,0.532763326227492,0.913182738923251
473,WP_HISTONE_MODIFICATIONS,35,Up,0.533167863191122,0.913182738923251
474,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Down,0.535270720981282,0.913182738923251
475,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Down,0.536020270041271,0.913182738923251
476,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Up,0.53818109635406,0.913182738923251
477,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,39,Down,0.541650927836645,0.913182738923251
478,WP_HIPPOYAP_SIGNALING,15,Up,0.543922849075153,0.913182738923251
479,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,19,Down,0.544438026307151,0.913182738923251
480,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,49,Down,0.544555044717148,0.913182738923251
481,WP_IL11_SIGNALING,40,Up,0.544558002162024,0.913182738923251
482,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,21,Up,0.545936525588469,0.913182738923251
483,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,88,Down,0.546328793107149,0.913182738923251
484,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Up,0.546814010113376,0.913182738923251
485,WP_VITAMIN_B12_DISORDERS,9,Up,0.547508351809463,0.913182738923251
486,WP_CORI_CYCLE,11,Down,0.547836980410558,0.913182738923251
487,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,94,Down,0.548037730190346,0.913182738923251
488,WP_TAR_SYNDROME,45,Up,0.548353527632862,0.913182738923251
489,WP_IL18_SIGNALING,190,Down,0.550223176070336,0.913182738923251
490,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,11,Down,0.55069645744719,0.913182738923251
491,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,11,Down,0.551234371329284,0.913182738923251
492,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,23,Up,0.55253842557968,0.913182738923251
493,WP_SEROTONIN_AND_ANXIETY,6,Down,0.553811021112282,0.913182738923251
494,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Up,0.555642369402328,0.913182738923251
495,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Up,0.5560277529204,0.913182738923251
496,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,21,Up,0.557033863536366,0.913182738923251
497,WP_TCELL_ACTIVATION_SARSCOV2,60,Down,0.557293038302177,0.913182738923251
498,WP_GASTRIN_SIGNALING,91,Down,0.559905062127581,0.913182738923251
499,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Up,0.561626533581677,0.913182738923251
500,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,60,Down,0.561951573927228,0.913182738923251
501,WP_IRINOTECAN_PATHWAY,5,Up,0.56266434857608,0.913182738923251
502,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,35,Down,0.564469014262085,0.913182738923251
503,WP_GLUCOCORTICOID_BIOSYNTHESIS,3,Down,0.564897700941371,0.913182738923251
504,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,11,Up,0.565222242588036,0.913182738923251
505,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,19,Up,0.565905539776515,0.913182738923251
506,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,11,Up,0.566859320890864,0.913182738923251
507,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Up,0.56868464296412,0.913182738923251
508,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Up,0.568985302130261,0.913182738923251
509,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Up,0.570214483110582,0.913182738923251
510,WP_GDNFRET_SIGNALING_AXIS,4,Down,0.570309680389996,0.913182738923251
511,WP_IL1_SIGNALING,51,Up,0.57167912923359,0.913182738923251
512,WP_INTERFERONMEDIATED_SIGNALING,14,Down,0.572674480479057,0.913182738923251
513,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,20,Down,0.572705831221305,0.913182738923251
514,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Up,0.573525529589334,0.913182738923251
515,WP_HOMOLOGOUS_RECOMBINATION,11,Down,0.575013039140424,0.913182738923251
516,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Up,0.575851377695172,0.913182738923251
517,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,60,Down,0.575888358776213,0.913182738923251
518,WP_TOLLLIKE_RECEPTOR_SIGNALING,80,Down,0.575945445096958,0.913182738923251
519,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Up,0.576271897164355,0.913182738923251
520,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,14,Up,0.576582681872942,0.913182738923251
521,WP_IL3_SIGNALING,45,Up,0.576688735732138,0.913182738923251
522,WP_WHITE_FAT_CELL_DIFFERENTIATION,22,Up,0.579811142779225,0.913841100016425
523,WP_MRNA_PROCESSING,124,Down,0.579987485275641,0.913841100016425
524,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,9,Down,0.58042755928316,0.913841100016425
525,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,13,Down,0.586513166233539,0.918650302179703
526,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.588079717437137,0.918650302179703
527,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,165,Down,0.588418032852281,0.918650302179703
528,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Down,0.589760793773893,0.918650302179703
529,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,27,Down,0.591947947581699,0.918650302179703
530,WP_DOPAMINERGIC_NEUROGENESIS,5,Down,0.593644148591783,0.918650302179703
531,WP_VALPROIC_ACID_PATHWAY,8,Down,0.59407324096919,0.918650302179703
532,WP_RAS_SIGNALING,114,Down,0.594958999922559,0.918650302179703
533,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,35,Up,0.596776183346545,0.918650302179703
534,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,39,Down,0.596797593197202,0.918650302179703
535,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Down,0.597777109636227,0.918650302179703
536,WP_CILIOPATHIES,116,Down,0.597897876771861,0.918650302179703
537,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,30,Up,0.597957833055152,0.918650302179703
538,WP_OVARIAN_INFERTILITY,21,Down,0.599804378142618,0.919670662714168
539,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,10,Down,0.600952456379634,0.919670662714168
540,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Up,0.601966251958365,0.919670662714168
541,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,20,Up,0.603465199340164,0.920256542431858
542,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,33,Up,0.604804826655293,0.920597752750216
543,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Up,0.609170375106182,0.924061036386921
544,WP_PDGFRBETA_PATHWAY,27,Down,0.609584130651672,0.924061036386921
545,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.611593137837912,0.924061036386921
546,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,55,Up,0.612888405274593,0.924061036386921
547,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Down,0.615231830210279,0.924061036386921
548,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,20,Down,0.615936349754568,0.924061036386921
549,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.617511132790786,0.924061036386921
550,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Up,0.617840070408886,0.924061036386921
551,WP_MTHFR_DEFICIENCY,18,Down,0.61902496997793,0.924061036386921
552,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,60,Down,0.621018456197365,0.924061036386921
553,WP_CHOLESTASIS,9,Down,0.621232535039992,0.924061036386921
554,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,18,Down,0.62547283432926,0.924061036386921
555,WP_EPO_RECEPTOR_SIGNALING,23,Down,0.626410879786802,0.924061036386921
556,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Up,0.626690141056193,0.924061036386921
557,WP_ALPHA_6_BETA_4_SIGNALING,24,Down,0.626707655742669,0.924061036386921
558,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Up,0.632033833272382,0.924061036386921
559,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,20,Down,0.632193130973637,0.924061036386921
560,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Down,0.632617392806232,0.924061036386921
561,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Down,0.632784541987518,0.924061036386921
562,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,10,Down,0.632977549558027,0.924061036386921
563,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Up,0.633170555095314,0.924061036386921
564,WP_GABA_RECEPTOR_SIGNALING,9,Down,0.634179615923521,0.924061036386921
565,WP_OSTEOBLAST_SIGNALING,3,Up,0.636165799235138,0.924061036386921
566,WP_HYPERTROPHY_MODEL,13,Down,0.636220119131378,0.924061036386921
567,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Down,0.639521426617709,0.924061036386921
568,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,23,Down,0.640275240820688,0.924061036386921
569,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Down,0.640696839386399,0.924061036386921
570,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,46,Up,0.64163333839452,0.924061036386921
571,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,49,Up,0.64177295622169,0.924061036386921
572,WP_CHOLESTEROL_METABOLISM,50,Down,0.642567597825776,0.924061036386921
573,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,26,Down,0.643421530261318,0.924061036386921
574,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,5,Down,0.644228405925541,0.924061036386921
575,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,33,Down,0.644430943190225,0.924061036386921
576,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,28,Down,0.645162614495596,0.924061036386921
577,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,26,Down,0.649929105093856,0.926465063659187
578,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,22,Up,0.650096684783475,0.926465063659187
579,WP_KCNQ2RELATED_EPILEPSIES,11,Down,0.650210026495357,0.926465063659187
580,WP_TRANSLATION_FACTORS,49,Up,0.653721118918894,0.928592588690103
581,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.653954295792666,0.928592588690103
582,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,19,Up,0.656818511521257,0.92984333039696
583,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Up,0.657089286813852,0.92984333039696
584,WP_GENES_CONTROLLING_NEPHROGENESIS,12,Down,0.658281492827657,0.929935328052769
585,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,3,Down,0.664694142565499,0.934511521444045
586,WP_NRXN1_DELETION_SYNDROME,2,Up,0.664717472142927,0.934511521444045
587,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,42,Up,0.670061097216002,0.934511521444045
588,WP_COPPER_HOMEOSTASIS,39,Down,0.670638158151639,0.934511521444045
589,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,22,Down,0.672561476374034,0.934511521444045
590,WP_PROLACTIN_SIGNALING,70,Down,0.672729512198118,0.934511521444045
591,WP_EGFEGFR_SIGNALING,138,Up,0.673145809991132,0.934511521444045
592,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Up,0.673680035895937,0.934511521444045
593,WP_APOPTOSIS_MODULATION_AND_SIGNALING,73,Down,0.675003066150117,0.934511521444045
594,WP_LEPTIN_SIGNALING,70,Down,0.675487118847571,0.934511521444045
595,WP_CANCER_PATHWAYS,294,Down,0.679370298047847,0.934511521444045
596,WP_BENZENE_METABOLISM,3,Down,0.679722247493709,0.934511521444045
597,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Down,0.68028831017206,0.934511521444045
598,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Down,0.681164169090339,0.934511521444045
599,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Up,0.68215668412703,0.934511521444045
600,WP_FRAGILE_X_SYNDROME,83,Down,0.682666432871123,0.934511521444045
601,WP_CALORIC_RESTRICTION_AND_AGING,7,Down,0.683139830235946,0.934511521444045
602,WP_VEGFAVEGFR2_SIGNALING,338,Up,0.684189220160953,0.934511521444045
603,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Down,0.684520208048503,0.934511521444045
604,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Up,0.685230097662934,0.934511521444045
605,WP_HEDGEHOG_SIGNALING_WP4249,25,Up,0.685308449058966,0.934511521444045
606,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,82,Down,0.688016737971594,0.936656450208854
607,WP_MELATONIN_METABOLISM_AND_EFFECTS,20,Up,0.692291353178721,0.940923173595461
608,WP_6Q16_COPY_NUMBER_VARIATION,5,Down,0.696431878956295,0.943917430561767
609,WP_MACROPHAGE_MARKERS,8,Up,0.696782685105596,0.943917430561767
610,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,45,Down,0.698451303550098,0.944023370483601
611,WP_LIPID_PARTICLES_COMPOSITION,5,Up,0.699149429533916,0.944023370483601
612,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,36,Down,0.704025825097383,0.946537943722969
613,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,71,Down,0.704225715776296,0.946537943722969
614,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,44,Down,0.704684740749355,0.946537943722969
615,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Down,0.706149224374607,0.946537943722969
616,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,76,Up,0.70674833131315,0.946537943722969
617,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.708772247572693,0.947710055506437
618,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,32,Down,0.713622025664855,0.951723795018917
619,WP_OMEGA9_FATTY_ACID_SYNTHESIS,10,Down,0.715789845769383,0.951723795018917
620,WP_MAPK_CASCADE,30,Down,0.716078090365377,0.951723795018917
621,WP_TYPE_III_INTERFERON_SIGNALING,6,Down,0.716934891422316,0.951723795018917
622,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,26,Up,0.717568928340148,0.951723795018917
623,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.718727863996518,0.951723795018917
624,WP_PROSTAGLANDIN_SIGNALING,24,Up,0.719849270414308,0.951723795018917
625,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,54,Down,0.72316493732571,0.953630369606492
626,WP_G_PROTEIN_SIGNALING,62,Up,0.725318745542598,0.953630369606492
627,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Down,0.731519971701765,0.953630369606492
628,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Down,0.732358826167198,0.953630369606492
629,WP_NANOMATERIAL_INDUCED_APOPTOSIS,17,Down,0.732445202959632,0.953630369606492
630,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,8,Down,0.732901885126323,0.953630369606492
631,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,8,Down,0.732901885126323,0.953630369606492
632,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Up,0.735515758501341,0.953630369606492
633,WP_MATRIX_METALLOPROTEINASES,10,Up,0.739537451721792,0.953630369606492
634,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,42,Down,0.740295234301132,0.953630369606492
635,WP_PLEURAL_MESOTHELIOMA,247,Down,0.740297524133935,0.953630369606492
636,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,135,Down,0.743268433239512,0.953630369606492
637,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,2,Up,0.744184081206309,0.953630369606492
638,WP_OREXIN_RECEPTOR_PATHWAY,114,Up,0.746645882267083,0.953630369606492
639,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,35,Up,0.747727328526577,0.953630369606492
640,WP_BDNFTRKB_SIGNALING,26,Up,0.749295545501256,0.953630369606492
641,WP_13Q1212_COPY_NUMBER_VARIATION,17,Up,0.751052314792117,0.953630369606492
642,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,26,Down,0.751515989965251,0.953630369606492
643,WP_CYTOSINE_METHYLATION,7,Up,0.751819626507619,0.953630369606492
644,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Up,0.754509695885408,0.953630369606492
645,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,1,Down,0.75480026808892,0.953630369606492
646,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,75,Up,0.755375953398039,0.953630369606492
647,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,23,Down,0.756643332632557,0.953630369606492
648,WP_IL2_SIGNALING,37,Up,0.757245764037771,0.953630369606492
649,WP_ENDOMETRIAL_CANCER,48,Down,0.757324241907949,0.953630369606492
650,WP_ZINC_HOMEOSTASIS,20,Up,0.759784177137063,0.953630369606492
651,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Up,0.759824867314571,0.953630369606492
652,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Down,0.759982161563647,0.953630369606492
653,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,27,Down,0.760690862781235,0.953630369606492
654,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Up,0.761154516950337,0.953630369606492
655,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Up,0.761516720056301,0.953630369606492
656,WP_MONOAMINE_TRANSPORT,11,Down,0.76196082705435,0.953630369606492
657,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,3,Down,0.763630382024443,0.953630369606492
658,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,9,Up,0.763769171591881,0.953630369606492
659,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,39,Down,0.766998310842126,0.953630369606492
660,WP_STEROID_BIOSYNTHESIS,2,Down,0.771170965717916,0.953630369606492
661,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,32,Up,0.77151702927749,0.953630369606492
662,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,122,Up,0.772132248418049,0.953630369606492
663,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,49,Down,0.772919376650273,0.953630369606492
664,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Up,0.773375291081102,0.953630369606492
665,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,15,Down,0.774812088381747,0.953630369606492
666,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,18,Down,0.774900279645612,0.953630369606492
667,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,8,Down,0.776041337991106,0.953630369606492
668,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,14,Down,0.776217888529167,0.953630369606492
669,WP_RANKLRANK_SIGNALING,47,Down,0.776305956160412,0.953630369606492
670,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Down,0.777979440425501,0.953630369606492
671,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,6,Up,0.778213127688866,0.953630369606492
672,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Up,0.778410730761691,0.953630369606492
673,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Up,0.779978467298635,0.953630369606492
674,WP_AMINO_ACID_METABOLISM,57,Up,0.780141058718696,0.953630369606492
675,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Down,0.784946930791325,0.953630369606492
676,WP_NONSMALL_CELL_LUNG_CANCER,58,Down,0.786698971960033,0.953630369606492
677,WP_CARDIAC_HYPERTROPHIC_RESPONSE,45,Up,0.787117770664117,0.953630369606492
678,WP_MELANOMA,53,Down,0.788635267681164,0.953630369606492
679,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Up,0.790411535479302,0.953630369606492
680,WP_VITAMIN_A1_AND_A5X_PATHWAYS,4,Up,0.791439044959928,0.953630369606492
681,WP_TRYPTOPHAN_METABOLISM,17,Down,0.793187133186222,0.953630369606492
682,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Down,0.79345157918389,0.953630369606492
683,WP_BREAST_CANCER_PATHWAY,83,Down,0.797594279407959,0.953630369606492
684,WP_WNT_SIGNALING_AND_PLURIPOTENCY,58,Up,0.797893894767242,0.953630369606492
685,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,3,Up,0.798390432574356,0.953630369606492
686,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,2,Up,0.800358903113328,0.953630369606492
687,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Up,0.801278453070663,0.953630369606492
688,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Up,0.801695620943091,0.953630369606492
689,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Up,0.802472283310939,0.953630369606492
690,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,81,Down,0.802978290673098,0.953630369606492
691,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,9,Up,0.803861910081888,0.953630369606492
692,WP_IL9_SIGNALING,15,Up,0.804219113462244,0.953630369606492
693,WP_EBOLA_VIRUS_INFECTION_IN_HOST,108,Up,0.80541788144957,0.953630369606492
694,WP_ENDOCHONDRAL_OSSIFICATION,26,Up,0.805966660221129,0.953630369606492
695,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,26,Up,0.805966660221129,0.953630369606492
696,WP_NUCLEAR_RECEPTORS,21,Up,0.806625714172378,0.953630369606492
697,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,41,Down,0.807405814628347,0.953630369606492
698,WP_UREA_CYCLE_AND_RELATED_DISEASES,4,Up,0.808168280794642,0.953630369606492
699,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,40,Down,0.810047435669643,0.953630369606492
700,WP_BARDETBIEDL_SYNDROME,62,Up,0.81006181602925,0.953630369606492
701,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,36,Down,0.810296835265637,0.953630369606492
702,WP_TGFBETA_RECEPTOR_SIGNALING,34,Up,0.812225679474218,0.953829595555485
703,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,47,Down,0.812778431121826,0.953829595555485
704,WP_RALA_DOWNSTREAM_REGULATED_GENES,11,Down,0.814007078560865,0.953885575867924
705,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,94,Up,0.815138583014407,0.953885575867924
706,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,11,Down,0.816648581193225,0.954075364332809
707,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,39,Up,0.817613675858541,0.954075364332809
708,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Down,0.818828839927705,0.954143775339487
709,WP_BURN_WOUND_HEALING,62,Down,0.825370339099019,0.959454603072463
710,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,46,Down,0.825712446280544,0.959454603072463
711,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Up,0.830140661100777,0.961859548287318
712,WP_METABOLIC_EPILEPTIC_DISORDERS,59,Down,0.832072645315157,0.961859548287318
713,WP_VITAMIN_D_METABOLISM,6,Down,0.832262745505711,0.961859548287318
714,WP_IL10_ANTIINFLAMMATORY_SIGNALING,11,Up,0.832445718154115,0.961859548287318
715,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,27,Down,0.834930431211783,0.963156394658956
716,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Down,0.836398673724356,0.963156394658956
717,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,25,Up,0.83756503745316,0.963156394658956
718,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.839017776852389,0.963156394658956
719,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Up,0.841234516024603,0.963156394658956
720,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,42,Down,0.842186356489262,0.963156394658956
721,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Down,0.842739204365074,0.963156394658956
722,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Down,0.842907778113656,0.963156394658956
723,WP_NETRINUNC5B_SIGNALING,35,Down,0.848644259166499,0.968370005272976
724,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,104,Up,0.852962176801365,0.970819743586635
725,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,12,Up,0.855111972800424,0.970819743586635
726,WP_KIT_RECEPTOR_SIGNALING,51,Up,0.855280110812408,0.970819743586635
727,WP_GPR40_PATHWAY,7,Down,0.855498125560586,0.970819743586635
728,WP_IL17_SIGNALING,24,Up,0.863162959284643,0.972024368037738
729,WP_ALZHEIMERS_DISEASE,183,Down,0.863464894295008,0.972024368037738
730,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,183,Down,0.863464894295008,0.972024368037738
731,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,16,Up,0.863565673742172,0.972024368037738
732,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Down,0.864215796491721,0.972024368037738
733,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Up,0.864509879247396,0.972024368037738
734,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,62,Down,0.864921448879192,0.972024368037738
735,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,47,Down,0.866326084355228,0.972024368037738
736,WP_GPCRS_OTHER,13,Down,0.867163557425182,0.972024368037738
737,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Up,0.870440480387639,0.973004102254335
738,WP_HUNGER_AND_SATIETY,2,Down,0.871921070880142,0.973004102254335
739,WP_15Q11Q13_COPY_NUMBER_VARIATION,29,Down,0.872499652613575,0.973004102254335
740,WP_TARGET_OF_RAPAMYCIN_SIGNALING,32,Down,0.872755194749343,0.973004102254335
741,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.879846977210768,0.974947775644538
742,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,16,Up,0.881357529429981,0.974947775644538
743,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Down,0.881987283914531,0.974947775644538
744,WP_BASE_EXCISION_REPAIR,29,Down,0.88243232573533,0.974947775644538
745,WP_MIRNA_BIOGENESIS,6,Down,0.883520121961258,0.974947775644538
746,WP_LIPID_METABOLISM_PATHWAY,23,Down,0.885440501622994,0.974947775644538
747,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Down,0.889012780410679,0.974947775644538
748,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,10,Up,0.89022432388783,0.974947775644538
749,WP_EFFECTS_OF_MFN2_MUTATION,17,Up,0.890292138005322,0.974947775644538
750,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,6,Down,0.892467581842118,0.974947775644538
751,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Up,0.893313972975245,0.974947775644538
752,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Down,0.894969653175995,0.974947775644538
753,WP_OPIOID_RECEPTOR_PATHWAYS,25,Down,0.89514634000013,0.974947775644538
754,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Down,0.895512959657616,0.974947775644538
755,WP_PI3KAKT_SIGNALING,175,Down,0.896031664051438,0.974947775644538
756,WP_HEART_DEVELOPMENT,15,Down,0.896435719080848,0.974947775644538
757,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,27,Up,0.898584854565828,0.974947775644538
758,WP_ACUTE_VIRAL_MYOCARDITIS,66,Down,0.898817374558427,0.974947775644538
759,WP_GPCRS_CLASS_A_RHODOPSINLIKE,46,Down,0.898918679136899,0.974947775644538
760,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,3,Up,0.898929039040931,0.974947775644538
761,WP_RETINOL_METABOLISM,5,Down,0.900165394837212,0.974947775644538
762,WP_WNT_SIGNALING_WP428,59,Up,0.903131806670193,0.974947775644538
763,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,25,Down,0.904813519989012,0.974947775644538
764,WP_SPHINGOLIPID_PATHWAY,21,Up,0.905372953883164,0.974947775644538
765,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Up,0.906038835176668,0.974947775644538
766,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,69,Down,0.906377545147559,0.974947775644538
767,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,9,Down,0.906405992629528,0.974947775644538
768,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,13,Up,0.908056372103327,0.97545118097037
769,WP_SECRETION_OF_HYDROCHLORIC_ACID_IN_PARIETAL_CELLS,1,Up,0.910042164378363,0.976313115230363
770,WP_NEOVASCULARIZATION_PROCESSES,23,Down,0.912437760688692,0.976665193411569
771,WP_METHYLATION_PATHWAYS,5,Up,0.913373863335389,0.976665193411569
772,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Up,0.915672833873869,0.976665193411569
773,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Down,0.91899991270434,0.976665193411569
774,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.919293555417246,0.976665193411569
775,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Down,0.924401921499299,0.976665193411569
776,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,5,Up,0.925594547486021,0.976665193411569
777,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,11,Up,0.92770849321335,0.976665193411569
778,WP_TCA_CYCLE_IN_SENESCENCE,9,Down,0.928179898979076,0.976665193411569
779,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Down,0.928360725039588,0.976665193411569
780,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,6,Up,0.928769487634746,0.976665193411569
781,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Up,0.929151691000373,0.976665193411569
782,WP_MICROTUBULE_CYTOSKELETON_REGULATION,35,Up,0.929418728072493,0.976665193411569
783,WP_WNT_SIGNALING_WP363,40,Up,0.930145827006765,0.976665193411569
784,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,62,Up,0.930728517336863,0.976665193411569
785,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,7,Down,0.930941655601605,0.976665193411569
786,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Down,0.931282582859423,0.976665193411569
787,WP_NPHP1_DELETION_SYNDROME,10,Up,0.93296595125588,0.976665193411569
788,WP_CCL18_SIGNALING,23,Up,0.933159626803243,0.976665193411569
789,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Down,0.936118188333216,0.976665193411569
790,WP_MINERALOCORTICOID_BIOSYNTHESIS,2,Down,0.936579164431454,0.976665193411569
791,WP_TROP2_REGULATORY_SIGNALING,42,Up,0.93717638856393,0.976665193411569
792,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,13,Down,0.939112023599149,0.976665193411569
793,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,50,Up,0.939480163551566,0.976665193411569
794,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Up,0.941818877605917,0.976665193411569
795,WP_OSTEOPONTIN_SIGNALING,12,Down,0.943354108058369,0.976665193411569
796,WP_GLYCOLYSIS_IN_SENESCENCE,10,Up,0.943503474190402,0.976665193411569
797,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Down,0.94351776866548,0.976665193411569
798,WP_KININKALLIKREIN_PATHWAY,2,Up,0.94478716975451,0.976753652941693
799,WP_FOXP3_IN_COVID19,9,Down,0.946523950796532,0.977324479858746
800,WP_VITAMIN_B12_METABOLISM,24,Down,0.948074105265169,0.977701421054705
801,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,30,Up,0.951515520536879,0.979564468434977
802,WP_INTEGRINMEDIATED_CELL_ADHESION,70,Down,0.952390430484077,0.979564468434977
803,WP_GASTRIC_CANCER_NETWORK_2,25,Up,0.956577026631112,0.979564468434977
804,WP_AEROBIC_GLYCOLYSIS,10,Down,0.956819390748272,0.979564468434977
805,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Down,0.956819390748272,0.979564468434977
806,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Up,0.957110580014836,0.979564468434977
807,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,25,Up,0.958383804966636,0.979564468434977
808,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Down,0.959379503630862,0.979564468434977
809,WP_HEPATITIS_B_INFECTION,118,Down,0.963135547213103,0.982183963474425
810,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Up,0.964552096352437,0.982414172210816
811,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Down,0.966560716574641,0.983246105023525
812,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Up,0.971215606860972,0.986379274668539
813,WP_METASTATIC_BRAIN_TUMOR,6,Up,0.972031939764269,0.986379274668539
814,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,13,Down,0.976289884999676,0.988196206501348
815,WP_B_CELL_RECEPTOR_SIGNALING,87,Down,0.976572051773764,0.988196206501348
816,WP_FLUOROACETIC_ACID_TOXICITY,6,Down,0.977415884248606,0.988196206501348
817,WP_MAPK_SIGNALING,157,Up,0.979263883758864,0.988852758997629
818,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,10,Up,0.98112824118545,0.98952420412958
819,WP_MALE_INFERTILITY,71,Up,0.988179445094083,0.995418854948252
820,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Up,0.990292556010411,0.996208465018803
821,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Up,0.99352596100139,0.996208465018803
822,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Up,0.993877630036498,0.996208465018803
823,WP_EICOSANOID_SYNTHESIS,13,Down,0.994859385592707,0.996208465018803
824,WP_DRAVET_SYNDROME,12,Up,0.995000939606659,0.996208465018803
825,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,14,Up,0.996432855727035,0.996432855727035
